Skip to main content

The Role of the Complement-derived Polypeptide C5a in Inflammatory Reactions

  • Chapter
Book cover Inflammatory Mediators

Abstract

The inflammatory process is the series of responses by living tissues to injurious or potentially injurious stimuli. Following the recognition of a potentially harmful agent within the tissue, chemical messages are sent to the microvascular bed. The purpose of these messages is to promote a change in the local microenvironment such that plasma components and selected blood cells accumulate at the inflammatory focus. The functional role of this accumulation may be seen as a mechanism by which neutralisation and/or removal of the inflammatory stimulus occurs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pillemer, L., Blum, L., LePow, I.H., Ross, O.A., Todd, E.W. and Wardlaw, A.C. (1954). The properdin system and immunity. 1. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science, 20, 279–285.

    Article  Google Scholar 

  2. Osier, R.G. and Sandberg, A.L. (1973). Alternate complement pathways. Prog. Allergy, 17, 51–92.

    Google Scholar 

  3. Gotz, O. and Muller-Eberhard, H.J. (1974). The role of properdin in the alternate pathway of complement activation. J. Exp. Med., 139, 44–57.

    Google Scholar 

  4. Muller Eberhard, H.J. (1969). Complement. Ann. Rev. Biochem., 38, 389–414.

    Article  Google Scholar 

  5. Ruddy, S., Gigli, I. and Austen, K.F. (1972). The complement system of man. N. Eng. J. Med., 287, 489–495, 545–549, 592–596, 642–646.

    Google Scholar 

  6. Tranurn-Jensen, J., Bhakdi, S., Bhakdi-Lehnen, B., Bjerrum, O.J. and Speth, V. (1978). Complement lysis: The ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes. Scand. J. Immunol., 7, 47–56.

    Google Scholar 

  7. Tschopp, J., Muller-Eberhard, H.J. and Podack, E.F. (1982). Formation of transmembrane tubules by spontaneous polymerization of the hydrophilic complement protein C9. Nature, 298, 534–538.

    Article  Google Scholar 

  8. Nelson, R.A. (1953). The immune adherence phenomenon. An immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. Science, 118, 733–735.

    Article  Google Scholar 

  9. Gigli, I. and Nelson, R.A. (1968). Complement dependent immune phagocytosis. 1. Requirements for C1, C4, C2 and C3. Exp. Cell Res., 51, 45–67.

    Article  Google Scholar 

  10. Landis, E.M. (1927). Micro-injection studies of capillary permeability. Am. J. Physiol., 81, 124–142.

    Google Scholar 

  11. Krogh, R. (1930). In The anatomy and physiology of capillaries, Yale University Press, p. 317.

    Google Scholar 

  12. Williams, T.J. (1979). Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br. J. Pharmacol., 65, 517–524.

    Google Scholar 

  13. Williams, T.J. and Morley, J. (1973). Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature, 246, 215–217.

    Article  Google Scholar 

  14. Lewis, A.J., Nelson, D.J. and Sugrue, M.F. (1975). On the ability of prostaglandin E, and arachidonic acid to modulate experimentally induced oedema in the rat paw. Br. J. Pharmacol., 55, 51–56.

    Google Scholar 

  15. Moncada, S., Ferreira, S.H. and Vane, J.R. (1973). Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature, 246, 217–219.

    Article  Google Scholar 

  16. Thomas, G. and West, G.B. (1974). Prostaglandins, kinin and inflammation in the rat. Br. J. Pharmacol., 50, 231–235.

    Google Scholar 

  17. Williams, T.J. (1976). The pro-inflammatory activity of E-, A-, D- and F-type prostaglandins and analogues 16, 16-dimethyl-PGE2 and (15S)-15-methyl-PGE2 in rabbit skin; the relationship between potentiation of plasma exudation and local blood flow changes. Br. J. Pharmacol., 56, 341–343P.

    Google Scholar 

  18. Kopaniak, M.M., Hay, J.B. and Movat, H.Z. (1978). The effect of hyperemia on vascular permeability. Microvasc. Res., 15, 77–82.

    Google Scholar 

  19. Williams, T.J. (1982). Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br. J. Pharmacol., 77, 505–509.

    Google Scholar 

  20. Williams, T.J. (1977). Chemical mediators of vascular responses in inflammation: a two mediator hypothesis. Br. J. Pharmacol., 61, 447–448P.

    Google Scholar 

  21. Williams, T.J. and Peck, M.J. (1977). Role of prostaglandin mediated vasodilatation in inflammation. Nature, 270, 530–532.

    Article  Google Scholar 

  22. Williams, T.J. and Jose, P.J. (1981). Mediation of increased vascular permeability after complement activation: histamine-independent action of rabbit C5a. J. Exp. Med., 153, 136–153.

    Google Scholar 

  23. Amelang, E., Prasad, CM., Raymond, R.M. and Grega, G.J. (1981). Interactions among inflammatory mediators on oedema formation in the canine forelimb. Circ. Res., 49, 298–306.

    Google Scholar 

  24. Prasad, CM., Adamski, S.W., Svensjo, E. and Grega, G.J. (1982). Pharmacological modifications of the oedema produced by combined infusions of prostaglandin E2 and bradykinin in canine forelimbs. J. Pharmacol. Exp. Ther., 220, 293–298.

    Google Scholar 

  25. Williams, T.J. (1978). A proposed mediator of increased vascular permeability in acute inflammation in the rabbit. J. Physiol. (Lond.), 281, 44–45P.

    Google Scholar 

  26. Jose, P.J., Peck, M.J., Robinson, C. and Williams, T.J. (1978). Characterization of a histamine-independent vascular permeability-increasing factor generated on exposure of rabbit plasma to zymosan. J. Physiol. (Lond.), 281, 13–14P.

    Google Scholar 

  27. Forrest, M.J., Jose, P.J. and Williams, T.J. (1981). Evidence that the complement fragment C5a mediates increased vascular permeability in response to zymosan in the peritoneal cavity of the rabbit. Br. J. Pharmacol., 74, 787P.

    Google Scholar 

  28. Jose, P.J., Forrest, M.J. and Williams, T.J. (1983). Detection of the complement fragment C5a in inflammatory exudates from the rabbit peritoneal cavity using radioimmunoassay. J. Exp. Med., 158, 2177–2182.

    Google Scholar 

  29. Hahn, F. and Oberdorf, A. (1950). Antihistaminica und anaphylaktoide Reaktionen. Z. ImmunForsch. Exp. Ther., 107, 528–538.

    Google Scholar 

  30. Hugli, T.E. and Muller-Eberhard, H.J. (1978). Anaphylatoxins: C3a and C5a. Adv. Immunol., 26, 1–53.

    Google Scholar 

  31. Jose, P.J., Forrest, M.J. and Williams, T.J. (1981). Human C5a des Arg increases vascular permeability. J. Immunol., 127, 2376–2380.

    Google Scholar 

  32. Stetson, C.A. (1951). Similarities in the mechanisms determining the Arthus and Schwartzman phenomena. J. Exp. Med., 94, 347–358.

    Google Scholar 

  33. Humphrey, J.H. (1955). The mechanism of Arthus reactions. 1) the role of the polymorphonuclear leukocytes and other factors in reversed passive Arthus reactions in rabbits. Br. J. Exp. Pathol., 36, 268–282.

    Google Scholar 

  34. Page, A.R. and Good, R.A. (1958). A clinical and experimental study of the function of neutrophils in the inflammatory response. Am. J. Pathol., 34, 645–656.

    Google Scholar 

  35. DeShazo, C.V., Henson, P.M. and Cochrane, CG (1972). Acute immunologic arthritis in rabbits. J. Clin. Invest., 51, 50–57.

    Article  Google Scholar 

  36. Willoughby, D.A and Spector, W.G. (1968). Inflammation in agranulocytic rats. Nature, 219, 1258.

    Article  Google Scholar 

  37. Snyderman, R., Phillips, J. and Mergenhagen, S.E. (1970). Polymorphonuclear leukocyte chemotactic activity in rabbit serum and guinea pig serum treated with immune complexes: evidence for C5a as the major chemotactic factor. Infect. Immun., 1, 521–525.

    Google Scholar 

  38. Damerau, B. and Vogt, W. (1976). Effect of hog anaphylatoxin (C5a) on vascular permeability and leukocyte emigration in vivo. Naunyn Schmiedebergs Arch. Pharmacol., 295, 237–241.

    Google Scholar 

  39. Fernandez, H.N., Henson, P.M., Otani, A. and Hugli, T.E (1978). Chemotactic response to human C3a and C5a anaphylatoxins. 1. Evaluations of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J. Immunol., 120, 109–115.

    Google Scholar 

  40. Goldstein, I., Hoffstein, S., Gallin, J. and Weissman, G. (1973). Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement. Proc. Natl. Acad. Sci. USA, 70, 2916–2920.

    Article  Google Scholar 

  41. Chenoweth, D.E. and Hugli, T.E. (1978). Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA, 75, 3934–3947.

    Article  Google Scholar 

  42. Sacks, T., Moldow, CF., Craddock, P.R., Bowers, T.K. and Jacob, H.S. (1978). Oxygen radicals mediate endothelial cell damage by complement stimulated granulocytes. J. Clin. Invest., 61, 1161–1167.

    Article  Google Scholar 

  43. Weissman, G., Smolen, J.E. and Korchak, H.M. (1980). Release of inflammatory mediators from stimulated neutrophils. N. Eng. J. Med., 303, 27–34.

    Google Scholar 

  44. Hammerschmidt, D.E., Harris, P.D., Wayland, J.H., Craddock, P.R. and Jacob, H.S. (1981). Complement-induced granulocyte aggregation in vivo. Am. J. Pathol., 102, 146–150.

    Google Scholar 

  45. Craddock, P.R., Hammerschmidt, D.E., Dalmasso, A.P., White, J.G. and Jacob, H.S. (1977). Complement (C5a)-induced granulocyte aggregation in vitro: a possible mechanism of complement-mediated leukostasis and leukopenia. J. Clin. Invest., 60, 260–264.

    Article  Google Scholar 

  46. Wedmore, C.V. and Williams, T.J. (1981). Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature, 289, 646–650.

    Article  Google Scholar 

  47. Majno, G. and Palade, G.E. (1961). Studies on inflammation. 1. The effect of histamine and serotinin on vascular permeability: an electron microscopic study. J. Biophys. Biochem. Cytol., 11, 571–605.

    Google Scholar 

  48. Bjork, J., Hedqvist, P. and Arfors, K.E. (1982). Increase in vascular permeability induced by leukotriene B4 and the role of polymorphonuclear leukocytes. Inflammation, 6, 189–200.

    Article  Google Scholar 

  49. Williams, T.J., Jose, P.J., Forrest, M.J., Wedmore, C.V. and Clough, G.F. (1984). Interactions between neutrophils and microvascular endothelial cells leading to cell emigration and plasma protein leakage. In White cell mechanics: Basic science and clinical aspects (eds. H.J. Meiselman, M.A. Lichtman, P.L. LeCelle) Alan R. Liss, Inc., New York, pp. 195–208.

    Google Scholar 

  50. Chenoweth, D.E. and Hugli, T.E. (1978). Initial characterization of the human polymorphonuclear leukocyte (PMN) receptor. J. Immunol., 120, 1768.

    Google Scholar 

  51. Craddock, P.R., Fehr, J., Brigham, K.L., Kronenberg, R.S. and Jacob, H.S. (1977). Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N. Eng. J. Med., 296, 769–774.

    Google Scholar 

  52. Craddock, P.R. (1982). Complement-mediated intravascular leukostasis and endothelial cell injury. In Pathobiology of the endothelial cell (eds. H.L. Nossel, H.J. Vogel) Academic Press, New York, pp. 369–386.

    Chapter  Google Scholar 

  53. Chenoweth, D.E., Cooper, S.W., Hugli, T.E., Stewart, R.W., Blackstone, E.H. and Kirklin, J.W. (1981). Complement activation during cardiopulmonary bypass. N. Eng. J. Med., 304, 497–503.

    Google Scholar 

  54. Allison, F. Jnr., Smith, M.R. and Wood, W.B. Jnr.(1955). Studies in the pathogenesis of acute inflammation. 1. The inflammatory reaction to thermal injury as observed in the rabbit ear chamber. J. Exp. Med., 102, 655–668.

    Article  Google Scholar 

  55. Hoover, R.L. and Karnovsky, M.J. (1982). Leukocyte-endothelial interactions. In Pathobiology of the endothelial cell (eds. H.L. Nossel, H.J. Vogel) Academic Press, New York, pp. 357–368.

    Chapter  Google Scholar 

  56. Tonnesen, M.G., Smedly, L.A. and Henson, P.M. (1984). Neutrophil-endothelial cell interactions: Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des Arg and formyl-methionyl-leucyl-phenylalanine in vitro. J. Clin. Invest., 74, 1581–1592.

    Article  Google Scholar 

  57. Webster, R.O., Larsen, G.L., Mitchell, B.C., Goins, A.J. and Henson, P.M. (1982). Absence of inflammatory lung injury in rabbits challenged intravascularly with complement-derived chemotactic mediators. Am. Rev., Respir. Dis., 125, 335–340.

    Google Scholar 

  58. Henson, P.M., Larsen, G.L., Webster, R.O., Mitchell, B.C., Goins, A.J. and Henson, J.E. (1982). Pulmonary microvascular alterations and injury induced by complement activation, neutrophil sequestration and prostaglandins. Ann. N.Y. Acad. Sci., 384, 287–300.

    Google Scholar 

  59. Worthen, G.S., Goins, A., Mitchell, B., Larsen, G., Reeves, J. and Henson, P.M. (1982). Effects of intravascular C5 fragments and platelet activating factor on lung injury and neutrophil accumulation in the rabbit. Am. Rev. Respir. Dis. Suppl., 125, 274.

    Google Scholar 

  60. Webster, R.O., Hong, S.R., Johnston, R.B.J. and Henson, P.M. (1980). Biological effects of the human complement fragments C5a and C5a des Arg on neutrophil function. Immunopharmacology, 2, 201–219.

    Article  Google Scholar 

  61. Cohnheim, J. (1889). In Lectures in general pathology, section 1. The pathology of the circulation. The Sydenham Society, London.

    Google Scholar 

  62. Cochrane, G.C. (1967). Mediators of the Arthus and related reactions. Prog. Allergy, 11, 1–35.

    Google Scholar 

  63. Hurley, J.V. (1963). An electron microscopic study of leukocytic emigration and vascular permeability in rat skin. Aust. J. Exp. Biol. Med., Sci., 41, 171–186.

    Google Scholar 

  64. Issekutz, A.C. (1981). Vascular responses during acute inflammation. Their relationship to in vivo neutrophil emigration. Lab. invest., 45, 435–441.

    Google Scholar 

  65. Henson, P.M. (1970). Release of vasoactive amines from rabbit platelets induced by sensitised mononuclear leukocytes and antigens. J. Exp. Med., 131., 287–306.

    Google Scholar 

  66. Hanahan, D.J., Demopoulos, C.A., Fehr, J. and Pinckard, R.N. (1980). Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J. Biol. Chem., 255, 5514–5516.

    Google Scholar 

  67. Camussi, G., Aglietta, M., Coda, R., Bussalina, F., Pacibello, W. and Tetta, C. (1981). Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of PAF: monocytes, polymorphonuclear leukocytes and basophils. Immunology, 42, 191–199.

    Google Scholar 

  68. Wedmore, C.V. and Williams T.J. (1981). Platelet-activating factor (PAF), a secretory product of polymorphonuclear leukocytes, increases vascular permeability in rabbit skin. Br. J. Pharmacol., 74, 916–917.

    Google Scholar 

  69. Hurley, J.V. (1964). Substances promoting leukocyte emigration. Ann. N.Y. Acad. Sci., 116, 918–935.

    Google Scholar 

  70. Logan, G. and Wilhelm, D.L. (1966). The inflammatory reaction in UV injury. Br. J. Exp. Pathol., 47, 286–299.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Copyright information

© 1985 The Contributors

About this chapter

Cite this chapter

Forrest, M.J., Jose, P.J., Williams, T.J. (1985). The Role of the Complement-derived Polypeptide C5a in Inflammatory Reactions. In: Higgs, G.A., Williams, T.J. (eds) Inflammatory Mediators. Satellite Symposia of the IUPHAR 9th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-07834-9_10

Download citation

Publish with us

Policies and ethics